Animalcare has launched Hydrocortisone Cutaneous Spray Solution (Hydrocortisone Aceponate 0.584 mg/ml), a topical spray for the symptomatic treatment of inflammatory and pruritic dermatoses and the alleviation of clinical signs associated with atopic dermatitis in dogs. 

Animalcare says hydrocortisone aceponate is a potent, topical anti-inflammatory, proven to quickly relieve itchy and inflamed skin in dogs.

The new product is applied as a spray, designed to make it easy to target affected areas of skin.

Hydrocortisone Cutaneous Spray Solution is presented in a 76 ml size with a two-year shelf life, six months once opened.

Animalcare Product Manager Eleanor Workman Wright said: “Skin problems are extremely common in dogs.

"They can often cause great discomfort to dogs and concern to their owners.

"We believe that Hydrocortisone Cutaneous Spray Solution will be a useful addition to the range of treatment options currently available to vets as they consider the most appropriate care plan for their patients.”

The RCVS Council has approved a new project to enhance veterinary clinical career pathways in three ways.

The first is the introduction of Specialist training and status for general practitioners in primary care, for which the RCVS project will now develop a new five-year curriculum and an implementation plan.

The RCVS will also be looking closer at the definition of veterinary clinical roles and developing guidance for the profession and wider public on the different clinical career statuses available to veterinary surgeons.

Thirdly, the College will identify different ways in which vets can access the teaching and learning opportunities, clinical experience/cases, supervision and support that is required for them to complete specialist training and obtain RCVS Specialist status.

This will include looking at how access to specialist training can be widened beyond the typical internship/residency model, to include training models more accessible from primary care practice, and for those at different career and life stages.

Kate Richards MRCVS, Chair of the RCVS Education Committee, said: “These exciting and progressive proposals are visionary as far as the career and development structure of the veterinary clinical profession is concerned.

“It means there will be new prospects for those in general practice and those who want to achieve Specialist status by different means, as well as a more defined career structure for the profession that will be clearer to the profession and general public alike.

"With around 75-80% of veterinary professionals working in clinical practice this project will deliver a substantial positive impact. 

“These are the early pages of a very exciting new chapter for veterinary clinical careers, and we will be asking for your help to write it, as we will be holding a number of consultations in the coming years, including on the programme for Specialist in Primary Care and the definition of clinical roles.

RCVS President Dr Sue Paterson FRCVS added: “There are two aspects of the project that I particularly welcome.

"First is the impact this could have on both recruitment and retention as vets are offered additional, and more diversified, career options and expanded roles in a variety of clinical settings.

"Second, as a specialist dermatologist myself, I really value the fact that we will be looking at ways to widen participation and increase accessibility to specialist training from primary care practice, as the residency/internship route is very intensive and not necessarily suitable for everyone. 

A similar process to develop and enhance clinical career pathways for veterinary nurses is now also being considered, this would include the development of an ‘Advanced Veterinary Nurse’ status and clearer information on the veterinary nursing role and what it entails.

The latest state-of-the-industry report examining the health and welfare of cattle in Great Britain has identified significant progress across key areas of mastitis, lameness and longevity, and for the first time looks in depth at the issues facing the dairy and beef sectors around antimicrobial resistance (AMR).

This third biennial offering from GB’s Cattle Health and Welfare Group also contains a summary of progress on endemic disease control with advances in eradicating Bovine Viral Diarrhoea (BVD) in each country highlighted.

The Chief Veterinary Officers of UK, Scotland and Wales have welcomed the publication of the report saying that as the possible impacts of the referendum on leaving the EU are considered, the importance of a GB focus on disease control is as important as ever.

In their joint forward, Nigel Gibbens, Sheila Voas and Christianne Glossop said: "The healthier our animals, the more attractive our products. The better our animal welfare, the greater the confidence of consumers in our production systems.

"With the UK Government placing AMR at the top of its risk register alongside terrorism and pandemic ’flu, it is heartening to see that CHAWG, in common with other livestock sectors, has grasped the nettle in looking first at how the cattle sector can better capture data on use of antimicrobials."

They go on to say that addressing AMR helps address other imperatives as an emphasis on sound animal husbandry and healthy animals kept to high welfare standards will help minimise routine reliance on antimicrobials: "Success in controlling endemic disease is one area of considerable importance, and here we can highlight CHAWG’s pivotal role in the development and promotion of national disease control programmes. These include the launch of the BVDFree scheme in England earlier this year, ongoing progress with BVD eradication in Scotland, the development of a Wales BVD scheme, and the Action Johne’s initiative."

In the report’s conclusion, RSPCA’s head of farm animals Marc Cooper points out that it is clear many positive initiatives are being pursued within the industry. He said: "Notable amongst these are those associated with dairy cow genetics, eliminating BVD, the national dairy cow welfare strategy and the development of a data hub for the collation of information relating to antimicrobial use.

"Indeed, some of these are starting to realise improvements in key areas, for example, dairy cow longevity is beginning to increase, and cow fertility figures and somatic cell counts appear to be moving in the right direction.

"However, there are still ongoing concerns relating to some important health and welfare issues. For example, despite the evidence suggesting the annual prevalence levels of cattle lameness are beginning to fall, there still appears to be no centralised database for recording it."

Chairman of CHAWG Tim Brigstocke says the contributed comments are encouraging and provide positive direction for future CHAWG activities. He also reassures that while this report sees a number of advances in highly topical areas, ‘core’ activities are not being ignored. He said: "Effective farm health planning remains the bedrock of good practice. And while we tend to focus on areas which need improvement, it’s worth mentioning that a delegation from the Food & Veterinary Office (FVO) of the European Commission recently visited and were impressed by the coordinated approach taken in this country."

The report can be downloaded from www.chawg.org.uk.

BSAVA PetSavers has launched a new research fellowship designed to support veterinary Early Career Researchers after they gain a postgraduate research qualification. 

The fellowship provides a grant of up to £35,000 for work in companion animal research to be spent over a maximum of two years.

Applications are open to veterinary surgeons who have completed a postgraduate qualification such as a PhD or Masters, and who are within the first four years after starting an academic post (Lecturer, Fellowship or above) and have received no more than £50,000 of funding in competitive external grants to date.

David Killick, Chair of the BSAVA PetSavers Grants Awarding Committee said: “BSAVA PetSavers is delighted to launch the PetSavers Research Fellowship.

"It is well recognised that the journey from completion of a PhD to becoming established as an independent researcher is one of the most challenging times of a researcher career.

“With this new grant BSAVA PetSavers will support exceptional veterinary professionals in the Early Career Researcher phase develop their research ideas by providing £35,000 towards research costs over a two-year period.

"Through this initiative BSAVA PetSavers aims to help these researchers reach their potential and in so doing expand the capacity for companion animal research in the UK.”.

Applications close on 28th February 2022, and a decision will be made by the end of May 2022.

To apply for the Research Fellowship, visit the BSAVA PetSavers website: https://www.petsavers.org.uk/Apply-for-funding/research-fellowship

Following its acquisition of SentrX Animal Care, TVM has added Remend Corneal Gel and Remend Dry Eye Lubricant Drops to its Corneal Focus range.

Remend Corneal Gel is used to aid the healing process of superficial corneal ulcers in dogs, cats and horses while Remend Dry Eye Lubricant Drops is designed to give long-lasting moisture and lubrication for dry eyes in dogs.

https://www.tvm-uk.com 

Intervet /Schering-Plough Animal Health has announced plans for a third National Vaccination Month Campaign to take place in May.

The campaign, which is aimed at owners of unvaccinated animals, is being fronted by TV presenter and wildlife expert Chris Packham. Intervet / Schering-Plough says it hopes the initiative will counter falling rates of pet vaccination that have been seen since the credit crunch.

In the lead up to National Vaccination Month, the company will be running a pet health awareness national and regional PR campaign backed up by print and TV advertising. 

Pet owners will be able to download a voucher for a discounted vaccination in May from http://www.nvmonline.co.uk/.  As well as dogs, cats and rabbits, horses will be included in the scheme for the second time.

During the last National Vaccination Month in June 2009, 1022 surgeries participated nationwide and an additional 40,000 animals were vaccinated as a result - 8,000 up on the first campaign run in 2008. According to Intervet / Schering-Plough, many practices saw more than 100 vouchers being redeemed.

The 2009 campaign came after more than a quarter of vets surveyed by Intervet reported concerns about falling levels of vaccination because of the credit crunch. Following the recession and public fears over the deficit, there are concerns that pet owners will cut back even further.

Angus Robinson from Intervet / Schering-Plough Animal Health said: "Research shows that the main reason why people don't vaccinate their pets is a lack of awareness of disease risk. We are also concerned that given the current pressures on household budgets, more people are deciding to cut back on vaccinating their animals with the real risk that this may have a potential effect on levels of herd immunity in the longer term."

He added: "We listened to practices which took part in NVM 2009 and have invested in improving the website to offer a simpler system for surgeries to download and log vouchers for their clients. The site will also drive pet owners to participating vets more quickly. Social media has taken off in a big way since our first campaign in 2008 and we will also be using Facebook and Twitter this time to reflect that. We are hoping that this will reach younger pet owners as data from our last campaign showed that pet owners in their 20s and early 30s were the age group least likely to vaccinate their animals."

Jane Carter of the Drove Veterinary Hospital in Swindon said: "National Vaccination Month is a golden opportunity to communicate the key preventative healthcare messages to new and existing clients. There was a significant outbreak of parvovirus in our area last summer which got a lot of publicity so we are expecting people will really catch onto the campaign this time."

Intervet / Schering-Plough Animal Health veterinary customers planning to take part in National Vaccination Month 2011 can log onto www.nvmonline.co.uk to complete the registration process.

Gemma Louise Cole has been struck off by the RCVS Veterinary Nurse Disciplinary Committee following her conviction for pet insurance fraud in 2024.

Mrs Cole pleaded guilty to fraud in July 2024 at Crawley Magistrates’ Court and was sentenced to eight months in prison suspended for 12 months, 20 days rehabilitation activity and a £187 victim surcharge.

The College opened its own disciplinary investigation against Mrs Cole after receiving the certificate of conviction, which related to more than £13,000 of pet insurance fraud.

It then proceeded with the hearing in Mrs Cole’s absence as she had not responded to any of the communications sent to her by the College on the matter.

Having found the charge against her proven by the certificate of conviction, the Committee then determined that the conviction amounted to serious professional misconduct.

Dr Kathryn Peaty MRCVS, chairing the committee and speaking on its behalf, said: “The respondent’s conduct… was plainly dishonest and contravened a fundamental tenet of the profession.

"She abused her professional position in order to commit the offence.

"The dishonest conduct in this case related directly to the respondent’s professional life, as she was working as a veterinary nurse when she completed and submitted the fraudulent claims.

“Her conduct also constituted a breach of the trust owed to her employer and to the insurance company to which her dishonest claims were submitted.

"She put her professional colleagues at risk as their names were used on the clinical records which purportedly supported her dishonest claims.

“Her misconduct was repeated and sustained over a period of many years.

"Her modus operandi was sophisticated and premeditated.

“The respondent’s conduct clearly had the potential to bring the profession into disrepute and to undermine public trust in the profession.

"A member of the public would be rightly appalled to learn that a veterinary nurse had abused her position by submitting false claims in this way.”

The Committee found that there were no mitigating factors, and that aggravating factors included the premeditated nature of Mrs Cole’s fraud, the clear breaches of trust in respect of her colleagues, her clients and the insurance companies, the significant financial gain made from her fraud and the fact that the fraudulent activities were sustained and repeated over a period of four and a half years.

Kathryn added: “Taking into account the gravity of her misconduct, the need to maintain standards of probity in the profession, especially in relation to practice records and the submission of insurance claim documents, as well as the maintenance of public confidence in the profession, the Committee has resolved to direct the Registrar to remove the respondent’s name from the Register.

www.rcvs.org.uk/disciplinary

A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health. 

In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.

Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.

Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".

The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.

The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.

In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.

Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.

*Reference
Schmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651

Dechra, the maker of Mirataz, is hosting a free webinar: ‘Feline pawsative about feline inappetence?’, at 8:00pm tonight.

Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on demand later, for those who miss it. 

Sam is an Internal Medicine and Feline Specialist and current ISFM Academy lead. 

She recently chaired and co-authored the ISFM guidelines on the management of the inappetent hospitalised cat.

The webinar, which counts for one hour’s CPD, will cover:

• Understanding why inappetence is particularly detrimental in cats
• Why early intervention to improve nutrition is important
• The types of appetite therapeutic and when to use them
• When to place feeding tubes and how to use them

Sarah Musgrave, Brand Manager at Dechra, said: “Inappetence is a common reason cats present to veterinary practices and it can be caused by multiple conditions.

"Management needs to look beyond just treating the underlying disease as factors such as stress, nausea and pain can play a significant role.

"Untreated inappetence has a substantial negative effect on recovery from illness and surgery, makes medicating cats difficult and may even hasten euthanasia decisions. 

"The ‘Feline pawsative about feline inappetence?’ webinar will help educate on feline weight loss, why intervention to improve nutrition is important and the practical steps to treating inappetence.”

https://thewebinarvet.com/webinars/feline-pawsative-about-feline-inappetence. 

The RCVS Disciplinary Committee has reprimanded and warned as to his future conduct a Hampshire veterinary surgeon found guilty of serious professional misconduct for cumulative failures to provide adequate professional care, and insufficient regard for animal welfare whilst treating a dog that had ingested broken glass.

The sanction was decided following a 12-month postponement of a decision ordered at a hearing on 19 November 2010.

At last week's hearing, the Committee was asked to decide what sanction would be appropriate in the case of Peter Ardle MacMahon for his treatment of a Cocker Spaniel called Wilfred, while working as a locum in Portsmouth. In 2010, the Committee found that Mr MacMahon had not removed the ingested glass from Wilfred's stomach or adequately checked that he had done so; had inadequately prevented abdominal contamination; and, had failed to communicate this contamination problem to Wilfred's usual veterinary surgeon. Considering these charges cumulatively, the Committee found that the treatment Mr MacMahon provided to Wilfred had fallen far short of the standard to be expected in the profession and amounted to serious professional misconduct.

Shortly prior to treating Wilfred, Mr MacMahon had returned to practice after a ten-year absence and, at last year's hearing, agreed to comply with undertakings regarding his professional development. These included performing at least 70 hours of medical and surgical continuing professional development (CPD); providing the Disciplinary Committee Chairman with quarterly CPD reports and two employer reports regarding his competence; observing 24 days of current practice by shadowing another veterinary surgeon; and, providing reports from this veterinary surgeon as to his competence and a case diary.

The Committee considered the factual findings from the November 2010 hearing and the concerns then expressed about Mr MacMahon's conduct and capabilities as a veterinary surgeon, as well as his compliance with the agreed undertakings. As advised by the Legal Assessor, the Committee's considerations of sanction began at the lowest level that would ensure that the welfare of animals was properly protected; that proper standards would be maintained among practitioners in the profession; and, that would be in the interests of the public.

Speaking on behalf of the Disciplinary Committee, Chairman Professor Peter Lees said: "The Committee is satisfied that the respondent had complied fully with the spirit of the requirements of the undertakings he had entered into on 18 November 2010. Indeed, the view is that the respondent has done well to achieve the level of compliance that he has, given that he had suffered a period of significant ill-health during the period since he entered into those undertakings.

"The ultimate decision is that the respondent's conduct [...] warrants the imposition of at least a reprimand," he continued. "However, it is also the Committee's firm view that the respondent must be warned about his future conduct so that he will know the Committee considers he needs to maintain the level of continuous professional development that he has achieved [over the last] 12 months, and to have constantly in mind the paramount obligation of all veterinary surgeons to ensure the welfare of animals under their care. 

"Such a warning as to future conduct should, and the Committee believes that it will, serve as a constant reminder to the respondent that he must undertake only those procedures, and only proffer professional advice, in the areas where he has the requisite up-to-date skills, knowledge and experience."

The Committee reprimanded Mr MacMahon and warned him as to his future conduct.

Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%¹, owner observed improvements in clinical signs³, and improved weight bearing ability^{2, 7}

The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant  effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis ^{1, 2,3}. 

According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase¹. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced⁴. High levels of omega-3 fatty acids can also help to reduce inflammation^5,6.

The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs^2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.

In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing². Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.

In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition³.  Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.

Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly." 

For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.

References
1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press
2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-73
3. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-66
4. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-19
5.  Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-358
6.  Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S
7.  Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.

A skirmish has broken out between academics from the University of Liverpool and the University of Winchester after the former published a study which refuted the claimed benefits of a canine vegan diet identified in an earlier study by the latter. 

In 2022, Winchester published the results of a study led by Professor Andrew Knight, which claimed the headline: "Vegan diets may be the healthiest to feed pet dogs, say researchers"^1,2.

For the study, 2,639 dog owners were invited to report their own opinion of seven indicators of their dog's health.

The researchers also looked at the prevalence of 22 specific health disorders, reported as being based on 'predictions by vet assessments', finding 49% prevalence in traditional meat diets, 43% for raw meat diets and 36% for vegan diets.

However, it was not clear in the report what "predictions by vet assessments" actually means. Whose predictions? The vets'? Or the owners'?

Closer examination of the original study reveals it was "owners' predictions of vet assessments".

Owner-reported opinion, otherwise known as anecdote, is of course notoriously unreliable, and if there is one thing more unreliable than owner-reported opinion, it would surely be owner-reported opinion of their vet's opinion.

Furthermore, the original study was of an observational design, and therefore could only suggest correlation, not causation.

Lastly, the original analysis only looked at the relationship between diet and owner observations/opinion, without considering the impact of other factors assessed by the study, such as the age of the dog and whether the owner was a vegan.

For the new study³, therefore, researchers at the University of Liverpool led by Professor Alex German re-analysed the data used for the original study, in particular correcting the data for confounding variables. 

When analysed in this way, significant illness in dogs correlated most strongly with the age of the dog, whether it was on medication, and the frequency of visit to the vet. 

Compared to these, the association between owner opinions of health and feeding vegan dog food was minimal. 

Co-author of the second study, Richard Barrett-Jolley, Professor of Neuropharmacology, said: “We know how seriously owners take their pet’s health.

"By revisiting and further interrogating these data, we have been able to draw more nuanced insights.

“Crucially, we cannot draw a firm conclusion as to what diet type is actually best for dogs; this was never possible given the nature of the original dataset and study design.

"However, we can conclude that variables other than dog diet are more strongly associated with owner opinions about the health of their dog.”

References

1. Knight A, Huang E, Rai N, Brown H (2022) Vegan versus meat-based dog food: Guardian-reported indicators of health. PLOS ONE 17(4): e0265662. https://doi.org/10.1371/journal.pone.0265662 
2. https://www.winchester.ac.uk/news-and-events/press-centre/media-articles/vegan-diets-may-be-the-healthiest-to-feed-pet-dogs-say-researchers.php 
3. Barrett-Jolley R, German AJ (2024) Variables associated with owner perceptions of the health of their dog: Further analysis of data from a large international survey. PLOS ONE 19(5): e0280173. https://doi.org/10.1371/journal.pone.0280173 

The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.

In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.

The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.

The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.

In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.

Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.

Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.

Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee. 

"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."

Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.

To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).

"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.

"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."

Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.